Thomas Holmes, MD
Neuromusculoskeletal Medicine & OMM · Marietta, GANPI 1326131467
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $79,809 of the $108,107 with a category attached, or 73.8%. 60 manufacturers reported payments, led by AbbVie at 27.1% of the total.
Across 983 payments — averaging $109.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$29K
- Jazz Pharmaceuticals Inc.$28K
- Greenwich Biosciences, Inc.$20K
- UCB, Inc.$19K
- SK Life Science, Inc.$3K
- Argenx US, Inc.$711
- plus $8K from 54 others
What the payments were for
- Consulting fees$7,0507%
- Speaking & faculty fees$79,80974%
- Travel & lodging$2,4742%
- Food & beverage$18,76917%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuromusculoskeletal medicine & omm providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 14 | $341,592 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 111 | $307,186 |
| FinteplaFenfluramine Hcl | 13 | $251,935 |
| XyremSodium Oxybate | 12 | $169,240 |
| BriviactBrivaracetam | 103 | $157,812 |
| UbrelvyUbrogepant | 105 | $154,770 |
| CopaxoneGlatiramer Acetate | 22 | $124,288 |
| Avonex (4 Pack)Interferon Beta-1a | 13 | $108,316 |
| XcopriCenobamate | 89 | $105,753 |
| KeppraLevetiracetam | 47 | $101,396 |
| Aimovig AutoinjectorErenumab-Aooe | 110 | $100,473 |
| QuliptaAtogepant | 69 | $83,595 |
| Nurtec OdtRimegepant Sulfate | 46 | $82,474 |
| VimpatLacosamide | 53 | $81,699 |
| LamictalLamotrigine | 63 | $81,457 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Fintepla, Briviact, Vimpat, Neupro | $19,379 | $509,606189 claims |
| PfizerOctagam, Nurtec Odt, Dilantin | $400 | $431,72393 claims |
| AbbVieUbrelvy, Qulipta | $29,319 | $238,365174 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $479 | $124,28822 claims |
| BiogenAvonex (4 Pack) | $395 | $108,31613 claims |
| SK Life Science, Inc.Xcopri | $2,850 | $105,75389 claims |
| GSKLamictal | $19 | $81,45763 claims |
| Grifols USA, LLCGamunex-C | $57 | $58,35811 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $234 | $54,22319 claims |
| Amneal Pharmaceuticals LLCRytary | $169 | $51,92045 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $404 | $31,36623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromusculoskeletal medicine & omm providers in Georgiaon file to place this against a meaningful peer group, so we don't.
Other neuromusculoskeletal medicine & omm in Marietta
- Joseph HormesMarietta$6K
- Luckana ChayaMarietta$109
- Noel HoltzMarietta$63
- Alan MaloonRoswell$74K
- Benjamin BarnesAugusta$50K
- Murray BerkowitzAlpharetta$2K
- Elizabeth WilletsCumming$33
- Curtis SmithAugusta$16
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.